2020
DOI: 10.1002/mdc3.12935
|View full text |Cite
|
Sign up to set email alerts
|

Generalized Chorea and JAK2V617F Mutation‐Positive Myeloproliferative Disorders

Abstract: View Supplementary Video 1

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
6
0
5

Year Published

2020
2020
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(11 citation statements)
references
References 6 publications
0
6
0
5
Order By: Relevance
“…However, most functional neuroimaging and pathological studies failed to detect different striatal characteristics in polycythemia vera patients with and without chorea. 3 Furthermore, chorea was reported in JAK2 V617Fpositive patients before or in the absence of hematological abnormalities meeting criteria for MPNs, 6,7 suggesting that blood hyperviscosity alone is not sufficient to explain chorea development.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…However, most functional neuroimaging and pathological studies failed to detect different striatal characteristics in polycythemia vera patients with and without chorea. 3 Furthermore, chorea was reported in JAK2 V617Fpositive patients before or in the absence of hematological abnormalities meeting criteria for MPNs, 6,7 suggesting that blood hyperviscosity alone is not sufficient to explain chorea development.…”
Section: Discussionmentioning
confidence: 99%
“…3,8 Recently, Betté and Moore speculated that, because JAK2 is expressed in vivo by striatal progenitor cells, the somatic gain-offunction variant JAK2 V617F might cause chorea through local inflammation and impaired neurosignaling in the striatum. 7,9 In other words, the acquisition of JAK2 V617F by hematopoietic cells could upregulate systemic cytokines with receptors in the striatum, leading to striatal overactivation and ultimately chorea. This mechanism might also contribute to chorea in autoimmune conditions 8 but does not explain why only a small percentage of JAK2 V617F -positive patients develop chorea.…”
Section: Case Reportmentioning
confidence: 99%
“…Aberrant activation of this pathway is commonly detected in multiple types of solid and hematological cancers [17]. JAK2 is also expressed in vivo by striatal progenitor cells in the central nervous system [18]. The JAK2V617F mutation disturbs JAK2 ′ s auto-inhibitory activity, leading to increased neuroinflammation, astrogliosis, and the intensification of cell proliferation, differentiation, and migration [13,18,19].…”
Section: The Link Between Mpd and Choreamentioning
confidence: 99%
“…The increased blood cell number represents a risk factor for hyperviscosity and thrombosis [18,19]. This prothrombotic state, leading to ischemic lesions in the basal ganglia, can cause chorea, a neurological complication described especially in PV, with a prevalence of 1-2.5% [22].…”
Section: The Link Between Mpd and Choreamentioning
confidence: 99%
“…The presence of chorea in PV is considered to be due to the expression of JAK2 in the striatum, with activation leading to astrogliosis and inflammation, suggesting the possibility of a direct mechanism for chorea, without the presence of polycythemia. 7 Various hypotheses have been postulated for the mechanism of chorea in secondary polycythemia, which is characterized by elevated hemoglobin and hematocrit levels without a JAK2 mutation. The response to phlebotomy, in the majority cases of sec-ondary polycythemia, suggests the role of increased hematocrit.…”
mentioning
confidence: 99%